Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Preceptorship on Uterine Cancer 2024: Lugano
- Start date
- 11 Jul 2024
- End date
- 12 Jul 2024
- Location
- Lugano, Switzerland
Learning objectives
- To learn about the fundamentals of diagnosis and staging of endometrial cancer
- To understand the importance of pathological and molecular characterization of endometrial cancer
- To understand the multidisciplinary treatment of endometrial cancer
- To learn about the recent advances in the systemic treatment of endometrial cancer and how to implement them in clinical practice
- To learn about novel targets and agents under investigation in endometrial cancer
- To learn the principles of diagnosis and treatment of uterine sarcoma
Accreditation
The programme of this event has been accredited with 10 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Ilaria Colombo, Switzerland
- Isabelle Ray-Coquard, France
Supported by
